13.07.2015 Views

Hypoglycaemia in Clinical Diabetes

Hypoglycaemia in Clinical Diabetes

Hypoglycaemia in Clinical Diabetes

SHOW MORE
SHOW LESS
  • No tags were found...

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

PrefaceIn the second edition of this book, we have cont<strong>in</strong>ued to emphasise the cl<strong>in</strong>ical significanceof hypoglycaemia to the person who has diabetes, particularly when receiv<strong>in</strong>g treatmentwith <strong>in</strong>sul<strong>in</strong>. S<strong>in</strong>ce the first edition of the book was published <strong>in</strong> 1999, new therapies haveemerged, <strong>in</strong>clud<strong>in</strong>g new <strong>in</strong>sul<strong>in</strong> analogues and <strong>in</strong>haled <strong>in</strong>sul<strong>in</strong>, and monitor<strong>in</strong>g systems arenow available that can provide cont<strong>in</strong>uous record<strong>in</strong>g of blood glucose. However, far fromm<strong>in</strong>imis<strong>in</strong>g the risk of hypoglycaemia <strong>in</strong> cl<strong>in</strong>ical practice, the newer treatments have beenshown to be as liable to cause hypoglycaemia as before, while cont<strong>in</strong>uous blood glucosemonitor<strong>in</strong>g has revealed that this side-effect of <strong>in</strong>sul<strong>in</strong> therapy is even more common thanwas believed previously. The frequency of severe hypoglycaemia <strong>in</strong> vulnerable groups suchas children and elderly people receiv<strong>in</strong>g <strong>in</strong>sul<strong>in</strong> therapy is unacceptably high, and presentspotentially serious risks to health as well as dim<strong>in</strong>ish<strong>in</strong>g their quality of life. Much scientificresearch <strong>in</strong> recent years has focused on the effects of hypoglycaemia on the bra<strong>in</strong>, provid<strong>in</strong>ga greater understand<strong>in</strong>g of the protean effects of this metabolic abnormality. New data andconcepts have been <strong>in</strong>corporated <strong>in</strong> this edition, particularly where these are of importanceto cl<strong>in</strong>ical practice.In updat<strong>in</strong>g and revis<strong>in</strong>g this book about hypoglycaemia, particular emphasis has beengiven to the risk factors for hypoglycaemia and how these may be reduced or avoided. Newchapters have been <strong>in</strong>cluded to discuss recognised moderators of hypoglycaemia and the roleof new glucose monitor<strong>in</strong>g systems, to address the <strong>in</strong>creas<strong>in</strong>g problem of hypoglycaemia <strong>in</strong>people with type 2 diabetes and the elderly person, and to acknowledge the major importanceof nocturnal hypoglycaemia, which is frequently not identified <strong>in</strong> cl<strong>in</strong>ical practice but canhave serious consequences, not only <strong>in</strong> its immediate morbidity, but also <strong>in</strong> promot<strong>in</strong>g thedevelopment of the acquired syndromes of hypoglycaemia.We are grateful for the expert assistance and support of the colleagues who havecontributed chapters, some of whom are new as authors for this edition. All have skillfullyhighlighted the relevance of the enhancement of scientific knowledge <strong>in</strong> this field to theeveryday management of diabetes, which we hope will assist all members of the diabetesteam <strong>in</strong> their efforts to prevent and manage the extremely common but unwanted scourgethat is hypoglycaemia.Brian M. FrierMiles Fisher

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!